Most eligible patients ‘have not had recent heart checks’ The reported results of a Heart Foundation survey suggest many at-risk patients have not been screened within the past two years.
Second SGLT2 inhibitor approved for heart failure Empagliflozin has been added to the PBS for symptomatic heart failure with reduced ejection fraction, regardless of diabetes status.
In Practice: Upskilling and networking opportunities A bumper edition of In Practice features new tips on named referrals, information on upcoming webinars, and much more.
‘Dire’ new data highlights RHD challenge Figures released by the AIHW illustrate the huge task in tackling rheumatic heart disease, which the Government has committed to eradicating by 2031.
Four patient groups that need GPs’ attention this Heart Week SPONSORED: The COVID-19 pandemic has made cardiovascular disease screening more critical than ever – but GPs can take practical steps to help.
Australia needs a modern approach to assessing heart attack risk CT scanning of the heart has changed the way coronary artery disease risk can be assessed, writes cardiologist Professor Girish Dwivedi.
Preventable risk factors in childhood linked with midlife CVD Five childhood risk factors, individually or combined, have been identified as predictors of fatal and non-fatal cardiovascular events in adulthood.
Have the benefits of statins been overstated? Researcher Paula Byrne writes on what she and her colleagues learned from a meta-analysis of 21 clinical trials involving 140,000 patients.
Why are Aboriginal Australians still dying from an entirely preventable disease? An AJGP editorial last year highlighted the abject failure in closing the gap for rheumatic heart disease. Since then, the divide has widened further still.
Foundation grants a ‘critical support’ for GP researchers Applications for the 2022 RACGP Foundation Grants and Awards open 1 March.